Cargando…
Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
The resistance of uropathogens to various antibiotics is increasing, but nitroxoline remains active in vitro against some relevant multidrug resistant uropathogenic bacteria. E. coli strains, which are among the most common uropathogens, are unanimously susceptible. Thus, nitroxoline is an option fo...
Autores principales: | Dobrindt, Ulrich, Wami, Haleluya T., Schmidt-Wieland, Torsten, Bertsch, Daniela, Oberdorfer, Klaus, Hof, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230139/ https://www.ncbi.nlm.nih.gov/pubmed/34071539 http://dx.doi.org/10.3390/antibiotics10060645 |
Ejemplares similares
-
Comparative Genomics of Emerging Lineages and Mobile Resistomes of Contemporary Broiler Strains of Salmonella Infantis and E. coli
por: Szmolka, Ama, et al.
Publicado: (2021) -
Nitroxoline: a potent antimicrobial agent against multidrug resistant Enterobacteriaceae
por: Cherdtrakulkiat, Rungrot, et al.
Publicado: (2019) -
Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014) -
Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015) -
Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency
por: Ritz, Sabrina, et al.
Publicado: (2020)